Literature DB >> 9353026

Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.

M Vasfi Marandi1, K R Mittal.   

Abstract

Two major outer membrane proteins of Pasteurella multocida, designated OmpH and OmpA, were characterized and shown to be related to the families of porin and heat-modifiable proteins, respectively. The backpack hybridoma tumor system in BALB/c mice was used to continuously deliver immunoglobulin G2b (IgG2b) monoclonal antibodies (MAbs) specific for OmpH (MAb MT1) and OmpA (MAb MT4.1). MAbs were detected in serum and peritoneal lavage samples of mice bearing hybridoma tumors by an enzyme-linked immunosorbent assay and an immunoblot assay. Highly significant protection was observed in mice bearing MT1 hybridoma tumors against both intraperitoneal and intranasal challenge infections with homologous nontoxigenic P. multocida strains possessing MAb MT1-reacting epitopes, whereas the mice bearing MT4.1 hybridoma tumors were not protected. The numbers of P. multocida organisms in the lungs of mice bearing MT1 hybridoma tumors were significantly less than those in lungs of mice bearing MT4.1 hybridoma tumors at 48 h postchallenge. These results indicate that the OmpH-specific MAb inhibited proliferation of P. multocida in the lungs. MAb MT1 was unable to kill P. multocida in vitro in the presence of complement. However, an enhanced phagocytosis by polymorphonuclear cells (PMNs) was observed in mice bearing MT1 hybridoma tumors. P. multocida induced a more extensive and rapid influx of PMNs into the peritoneal cavity of mice bearing MT1 hybridoma tumors than of mice bearing MT4.1 hybridoma tumors. The results of this study demonstrate for the first time that IgG MAbs against OmpH of P. multocida are involved in the protection of mice against lethal challenge infection by means of opsonization and inhibition of proliferation of P. multocida as a result of increased influx of PMNs into the infection site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353026      PMCID: PMC175647          DOI: 10.1128/iai.65.11.4502-4508.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Factors involved in bactericidal activity of sheep serum.

Authors:  K R Mittal; D G Ingram
Journal:  Am J Vet Res       Date:  1975-08       Impact factor: 1.156

2.  Immune responses to Pasteurella multocida in the mouse.

Authors:  F M Collins
Journal:  J Reticuloendothel Soc       Date:  1976-05

3.  Immunologic response of turkeys to an avirulent Pasteurella multocida vaccine in the drinking water.

Authors:  B W Bierer; W T Derieux
Journal:  Poult Sci       Date:  1972-03       Impact factor: 3.352

4.  Serogroup F, a new capsule serogroup of Pasteurella multocida.

Authors:  R B Rimler; K R Rhoades
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

5.  Studies on Pasteurella multocida. VI. Nature of systemic immunity and analysis of the correlation between levels of immunity induced by various fowl cholera vaccines and protection against challenge.

Authors:  S K Dua; S K Maheswaran
Journal:  Avian Dis       Date:  1978 Oct-Dec       Impact factor: 1.577

6.  Cloning, sequencing, expression, and protective capacity of the oma87 gene encoding the Pasteurella multocida 87-kilodalton outer membrane antigen.

Authors:  C G Ruffolo; B Adler
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  Characterization of an outer membrane protein of Pasteurella multocida belonging to the OmpA family.

Authors:  M Marandi; K R Mittal
Journal:  Vet Microbiol       Date:  1996-12       Impact factor: 3.293

8.  Fowl cholera; cross-protective turkey antisera and IgG antibodies induced with Pasteurella multocida-infected tissue bacterins.

Authors:  P A Rebers; K L Heddleston; B Wright; K Gillette
Journal:  Carbohydr Res       Date:  1975-03       Impact factor: 2.104

Review 9.  Pasteurellosis: Pasteurella multocida and Pasteurella hemolytica.

Authors:  G R Carter
Journal:  Adv Vet Sci       Date:  1967

10.  Immune mechanism in Pasteurella multocida-infected mice.

Authors:  J B Woolcock; F M Collins
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

View more
  9 in total

1.  Evaluation of immunopathologic effects of aqueous extract of Echinacea purpurea in mice after experimental challenge with Pasteurella multocida serotype A.

Authors:  A Rezaie; D Gharibi; M Ghorbanpoor; S Anbari; M Pourmahdi Broojeni
Journal:  Iran J Vet Res       Date:  2014       Impact factor: 1.376

Review 2.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Protective immunity conferred by the C-terminal fragment of recombinant Pasteurella multocida toxin.

Authors:  Jeongmin Lee; Hae-Eun Kang; Hee-Jong Woo
Journal:  Clin Vaccine Immunol       Date:  2012-07-25

4.  The C-terminal domain of Salmonella enterica serovar typhimurium OmpA is an immunodominant antigen in mice but appears to be only partially exposed on the bacterial cell surface.

Authors:  Shiva P Singh; Yvonne U Williams; Stephanie Miller; Hiroshi Nikaido
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  Isolation, antimicrobial resistance, and virulence genes of Pasteurella multocida strains from swine in China.

Authors:  Xibiao Tang; Zhanqin Zhao; Junyong Hu; Bin Wu; Xuwang Cai; Qigai He; Huanchun Chen
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

6.  Identification of novel surface-exposed proteins of Rickettsia rickettsii by affinity purification and proteomics.

Authors:  Wenping Gong; Xiaolu Xiong; Yong Qi; Jun Jiao; Changsong Duan; Bohai Wen
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

7.  Diversity of avian Pasteurella multocida strains based on capsular PCR typing and variation of the OmpA and OmpH outer membrane proteins.

Authors:  Robert L Davies; Roslyn MacCorquodale; Bridget Caffrey
Journal:  Vet Microbiol       Date:  2003-02-02       Impact factor: 3.293

Review 8.  Spatial, Temporal, and Demographic Patterns in the Prevalence of Hemorrhagic Septicemia in 41 Countries in 2005-2019: A Systematic Analysis with Special Focus on the Potential Development of a New-Generation Vaccine.

Authors:  Reyad Almoheer; Mohd Effendy Abd Wahid; Hidayatul Aini Zakaria; Mohd Anuar Bin Jonet; Muhanna Mohammed Al-Shaibani; Adel Al-Gheethi; Siti Nor Khadijah Addis
Journal:  Vaccines (Basel)       Date:  2022-02-17

9.  Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles.

Authors:  Sandro Roier; Judith C Fenninger; Deborah R Leitner; Gerald N Rechberger; Joachim Reidl; Stefan Schild
Journal:  Int J Med Microbiol       Date:  2013-05-10       Impact factor: 3.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.